Delta or Omicron BA.1/2-neutralizing antibody levels and T-cell reactivity after triple-vaccination or infection
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Erschienen in
-
In: Allergy(77), H. 10, S.3130-3133 - ISSN 0105-4538
In: Wiley, Oxford
- Klassifikation
-
Medizin, Gesundheit
- Ereignis
-
Veröffentlichung
- (wo)
-
Kiel
- (wer)
-
Universitätsbibliothek Kiel
- (wann)
-
2022
- Urheber
-
Rose, Ruben
Neumann, Franziska
Müller, Sina
Bäumler, Carina
Schäfer, Miriam
Schön, Frieda
Römpke, Janine
Schulze, Simone
Weyer, Dirk
Grobe, Olaf
Lorentz, Thomas
Fickenscher, Helmut
Krumbholz, Andi
- URN
-
urn:nbn:de:gbv:8:3-2024-00526-8
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:48 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Rose, Ruben
- Neumann, Franziska
- Müller, Sina
- Bäumler, Carina
- Schäfer, Miriam
- Schön, Frieda
- Römpke, Janine
- Schulze, Simone
- Weyer, Dirk
- Grobe, Olaf
- Lorentz, Thomas
- Fickenscher, Helmut
- Krumbholz, Andi
- Universitätsbibliothek Kiel
Entstanden
- 2022
Ähnliche Objekte (12)
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective study
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective study
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses
Effective Neutralizing Antibody Response Against SARS-CoV-2 Virus and Its Omicron BA.1 Variant in Fully Vaccinated Hematological Patients
Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Author Correction: Omicron BA.4/BA.5 escape neutralizing immunity elicited by BA.1 infection
Anatomy of Omicron BA.1 and BA.2 neutralizing antibodies in COVID-19 mRNA vaccinees
Omicron BA.1 neutralizing antibody response following Delta breakthrough infection compared with booster vaccination of BNT162b2
Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies
The SARS-CoV-2 Omicron BA.1 spike G446S mutation potentiates antiviral T-cell recognition
BA.2 and BA.5 omicron differ immunologically from both BA.1 omicron and pre-omicron variants
Serum neutralizing capacity and T-cell response against the omicron BA.1 variant in seropositive children and their parents one year after SARS-CoV-2 infection
Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective study
Bivalent COVID-19 mRNA booster vaccination (BA.1 or BA.4/BA.5) increases neutralization of matched Omicron variants
Broadly neutralizing and protective nanobodies against SARS-CoV-2 Omicron subvariants BA.1, BA.2, and BA.4/5 and diverse sarbecoviruses